This large body of evidence consistent with Egr1 behaving as a tumor suppressor in hematopoietic cells, both in vivo & in vitro and in both humans and mice, led us to ask if Egr1 plays a role in Chronic Myelogenous Leukemia (CML). The gene discussed is EGR1; the disease is neoplasm.